HomeBUSINESS
BUSINESS

Mitsubishi Tanabe Seeks to Block Talion Generic Launches by 3 Makers
(Sep.26.2017)

Mitsubishi Tanabe Pharma is seeking to block generic launches for its flagship anti-allergy treatment Talion (bepotastine) by three generic makers, claiming that their products infringe its patents for the 20-billion-yen originator drug ...
(LOG IN FOR FULL STORY)

News Calendar